Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

317
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
317
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.8K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.8K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

684
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
684
Estimating Population Mean with Unknown Standard Deviation01:22

Estimating Population Mean with Unknown Standard Deviation

9.1K
In practice, we rarely know the population standard deviation. In the past, when the sample size was large, this did not present a problem to statisticians. They used the sample standard deviation s as an estimate for σ and proceeded as before to calculate a confidence interval with close enough results. However, statisticians ran into problems when the sample size was small. A small sample size caused inaccuracies in the confidence interval.
William S. Gosset (1876–1937) of the...
9.1K
Estimating Population Standard Deviation01:26

Estimating Population Standard Deviation

3.5K
When the population standard deviation is unknown and the sample size is large, the sample standard deviation s is commonly used as a point estimate of σ. However, it can sometimes under or overestimate the population standard deviation. To overcome this drawback, confidence intervals are determined to estimate population parameters and eliminate any calculation bias accurately. However, this only applies to random samples from normally distributed populations. Knowing the sample mean and...
3.5K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.5K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A two-stage joint modeling approach for multiple longitudinal markers and time-to-event data.

Statistical methods in medical research·2026
Same author

A Bayesian joint bent-cable model for longitudinal measurements and survival time with heterogeneous random-effects distributions.

Journal of biopharmaceutical statistics·2025
Same author

Joint modeling of zero-inflated longitudinal measurements and time-to-event outcomes with applications to dynamic prediction.

Statistical methods in medical research·2024
Same author

GCPBayes pipeline: a tool for exploring pleiotropy at the gene level.

NAR genomics and bioinformatics·2023
Same author

General location multivariate latent variable models for mixed correlated bounded continuous, ordinal, and nominal responses with non-ignorable missing data.

Journal of applied statistics·2022
Same author

Analysis of mixed correlated overdispersed binomial and ordinal longitudinal responses: LogLindley-Binomial and ordinal random effects model.

Journal of applied statistics·2022

Related Experiment Video

Updated: Apr 14, 2026

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

43.0K

Robust modeling of differential gene expression data using normal/independent distributions: a Bayesian approach.

Mojtaba Ganjali1, Taban Baghfalaki2, Damon Berridge3

  • 1School of Biological Science, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran; Department of Statistics, Faculty of Mathematical Sciences, Shahid Beheshti University, Tehran, Iran.

Plos One
|April 25, 2015
PubMed
Summary

This study introduces robust statistical models for identifying differentially expressed genes in microarray data, especially when outliers are present. The findings highlight the importance of model selection for accurate gene expression analysis.

More Related Videos

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress
05:22

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress

Published on: July 29, 2022

4.1K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K

Related Experiment Videos

Last Updated: Apr 14, 2026

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

43.0K
Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress
05:22

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress

Published on: July 29, 2022

4.1K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K

Area of Science:

  • Genomics
  • Bioinformatics
  • Statistical Modeling

Background:

  • Gene expression microarray data analysis is crucial for understanding biological conditions.
  • Identifying differentially expressed genes is often complicated by the presence of outliers and limited replicates.
  • Traditional methods may not adequately address the challenges posed by non-normal data distributions in gene expression.

Purpose of the Study:

  • To develop and evaluate robust statistical models for identifying differentially expressed genes using gene expression microarray data.
  • To explore the utility of normal/independent distributions, including Student's t, slash, contaminated normal, and Laplace distributions, for robust gene expression analysis.
  • To compare the performance of these robust models against traditional approaches in the presence of outliers.

Main Methods:

  • Application of robust modeling using normal/independent distributions for gene expression data.
  • Utilizing a Bayesian approach with Markov Chain Monte Carlo (MCMC) for parameter estimation.
  • Analysis of two publicly available gene expression datasets and simulation studies to validate the proposed methods.

Main Results:

  • The choice of statistical model significantly impacts the identification of differentially expressed genes, particularly with small replicate numbers and outlying data.
  • Robust models demonstrated flexibility and effectiveness in detecting differentially expressed genes under various conditions.
  • Performance comparisons using statistical criteria and ROC curves indicated the advantages of the proposed robust approach.

Conclusions:

  • Robust modeling using advanced distributional assumptions is essential for accurate differential gene expression analysis from microarray data.
  • The proposed Bayesian approach with MCMC provides a flexible framework for handling outliers and improving the reliability of gene expression studies.
  • These findings underscore the importance of considering data distribution and robustness in bioinformatics pipelines for gene expression analysis.